IGF-1 LR3 Research: Growth Factor Mechanisms and Receptor Signaling
Exploring insulin-like growth factor-1 long arginine 3 (IGF-1 LR3) — its enhanced potency, receptor binding properties, and applications in cell proliferation and differentiation research.
The IGF System: An Overview
The insulin-like growth factor (IGF) system comprises two ligands (IGF-1 and IGF-2), two receptors (IGF-1R and IGF-2R), six IGF-binding proteins (IGFBP-1 through -6), and several IGFBP proteases. This intricate regulatory network controls cell growth, differentiation, survival, and metabolism across virtually every tissue type.
IGF-1R is a tyrosine kinase receptor structurally similar to the insulin receptor. Ligand binding triggers receptor autophosphorylation, recruitment of IRS-1/IRS-2 adaptor proteins, activation of PI3K/Akt pathway (cell survival and protein synthesis), and activation of Ras/MAPK pathway (cell proliferation).
What Makes IGF-1 LR3 Different?
IGF-1 LR3 (Long Arg3-IGF-1) is a synthetic analog of human IGF-1 with two modifications:
- Arginine substitution at position 3: Replacement of glutamate with arginine reduces binding to IGFBPs by approximately 100-fold
- N-terminal extension: A 13-amino-acid extension further reduces IGFBP affinity
The net effect is a peptide that is functionally more potent than native IGF-1 because it remains unbound and bioavailable rather than sequestered by IGFBPs. In research settings, this means lower effective concentrations, more predictable dose-response relationships, reduced interference from endogenous IGFBP expression levels, and longer half-life in culture.
Receptor Binding Profile
IGF-1 LR3 maintains high affinity for IGF-1R while showing minimal cross-reactivity with the insulin receptor — important for research applications where insulin receptor activation would introduce confounding variables.
Research Applications
- Cell proliferation assays: C2C12 and L6 myoblast lines, primary fibroblasts, neural progenitor cells
- Differentiation studies: Myogenic, osteogenic, and chondrogenic differentiation
- Survival/anti-apoptosis assays: Protection against serum-withdrawal-induced apoptosis
Storage and Handling
Store lyophilized at -20°C. Reconstitute in 10mM HCl or 100mM acetic acid initially (IGF-1 LR3 is poorly soluble at neutral pH), then dilute to working concentration in assay buffer. Do not store reconstituted solutions — aliquot and freeze at -80°C.
Malice Research Lab supplies IGF-1 LR3 (IG1) with full HPLC and MS characterization.